Compound ID | 77
SAL200
Synonym(s): N-Rephasin | LSVT-1701 | Tonabacase
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Natural product; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall degradation |
| Target Pathogen: | Active against Staphylococcus aureus |
| Institute where first reported: | iNtRON Biotechnology, Inc., Seongnam, Republic of Korea; Lysovant |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Phase 2 (NCT05329168) |
| Development status: | Inactive |
| Reason Dropped: | Enrollment terminated - "business decision; not related to any safety concerns" |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.